Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity

Por Jochems, Caroline, Schlom, Jeffrey
Publicado em 2011

The role of soluble CD40L in immunosuppression

Por Schlom, Jeffrey, Jochems, Caroline, Gulley, James L., Huang, Jianping
Publicado em 2013

Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation

Por Jochems, Caroline, Islander, Ulrika, Erlandsson, Malin, Verdrengh, Margareta, Ohlsson, Claes, Carlsten, Hans
Publicado em 2005

Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer

Por Tucker, Jo A., Jochems, Caroline, Gulley, James L., Schlom, Jeffrey, Tsang, Kwong Y.
Publicado em 2012

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine

Por Smalley Rumfield, Claire, Pellom, Samuel T, Morillon II, Y Maurice, Schlom, Jeffrey, Jochems, Caroline
Publicado no J Immunother Cancer (2020)

Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density

Por Grahnemo, Louise, Jochems, Caroline, Andersson, Annica, Engdahl, Cecilia, Ohlsson, Claes, Islander, Ulrika, Carlsten, Hans
Publicado no J Endocrinol (2015)

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis

Por Islander, Ulrika, Jochems, Caroline, Stubelius, Alexandra, Andersson, Annica, Lagerquist, Marie K, Ohlsson, Claes, Carlsten, Hans
Publicado em 2011

An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression

Por Fujii, Rika, Jochems, Caroline, Tritsch, Sarah R., Wong, Hing C., Schlom, Jeffrey, Hodge, James W.
Publicado no Cancer Immunol Immunother (2018)

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)

Por Boyerinas, Benjamin, Tucker, Jo A, Poole, Diane J, Jochéms, Caroline, Palena, Claudia, Schlom, Jeffrey, Tsang, Kwong Y
Publicado em 2013

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

Por Jochems, Caroline, Tucker, Jo A, Vergati, Matteo, Boyerinas, Benjamin, Gulley, James L, Schlom, Jeffrey, Tsang, Kwong-Yok
Publicado em 2013

Antibody-dependent cellular cytotoxicity (ADCC) activity of a novel anti-PD-L1 antibody avelumab (MSB0010718C) on human tumor cells

Por Boyerinas, Benjamin, Jochems, Caroline, Fantini, Massimo, Heery, Christopher R., Gulley, James L., Tsang, Kwong Yok, Schlom, Jeffrey
Publicado no Cancer Immunol Res (2015)

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

Por Jochems, Caroline, Tucker, Jo A., Vergati, Matteo, Boyerinas, Benjamin, Gulley, James L., Schlom, Jeffrey, Tsang, Kwong-Yok
Publicado no Cancer Immunol Immunother (2013)

Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1^*/*mice with collagen-induced chronic arthritis

Por Gjertsson Inger, Lagerquist Marie, Engdahl Cecilia, Erlandsson Malin, Islander Ulrika, Jochems Caroline, Ohlsson Claes, Holmdahl Rikard, Carlsten Hans
Publicado em 2010-12-01

Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1(*/* )mice with collagen-induced chronic arthritis

Por Jochems, Caroline, Islander, Ulrika, Erlandsson, Malin, Engdahl, Cecilia, Lagerquist, Marie, Gjertsson, Inger, Ohlsson, Claes, Holmdahl, Rikard, Carlsten, Hans
Publicado em 2010

ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody

Por Jochems, Caroline, Hodge, James W., Fantini, Massimo, Tsang, Kwong Y., Vandeveer, Amanda J., Gulley, James L., Schlom, Jeffrey
Publicado no Int J Cancer (2017)

Pan-Bcl-2 Inhibitor, GX15-070 (Obatoclax), Decreases Human T Regulatory Lymphocytes While Preserving Effector T Lymphocytes: a Rationale for Its Use in Combination Immunotherapy

Por Kim, Peter S., Jochems, Caroline, Grenga, Italia, Donahue, Renee N., Tsang, Kwong Y., Gulley, James L., Schlom, Jeffrey, Farsaci, Benedetto
Publicado em 2014

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody

Por Boyerinas, Benjamin, Jochems, Caroline, Hance, Kenneth W, Heery, Christopher R, Gulley, James L, Sabzevari, Helen, Schlom, Jeffrey, Tsang, Kwong
Publicado no J Immunother Cancer (2014)

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances

Por Lind, Hanne, Gameiro, Sofia R, Jochems, Caroline, Donahue, Renee N., Strauss, Julius, Gulley, James L, Palena, Claudia, Schlom, Jeffrey
Publicado no J Immunother Cancer (2020)

Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine

Por Farsaci, Benedetto, Jochems, Caroline, Grenga, Italia, Donahue, Renee N, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Schlom, Jeffrey
Publicado em 2013

The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy

Por Roselli, Mario, Formica, Vincenzo, Cereda, Vittore, Jochems, Caroline, Richards, Jacob, Grenga, Italia, Orlandi, Augusto, Ferroni, Patrizia, Guadagni, Fiorella, Schlom, Jeffrey
Publicado no Oncoimmunology (2016)